{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:34:43Z","timestamp":1760978083232},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s1353-8020(02)00039-1","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T12:54:12Z","timestamp":1034168052000},"page":"7-13","source":"Crossref","is-referenced-by-count":4,"title":["Evidence-based medicine (EBM) applied to Parkinson's disease treatment"],"prefix":"10.1016","volume":"9","author":[{"given":"Cristina","family":"Sampaio","sequence":"first","affiliation":[]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1353-8020(02)00039-1_BIB1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2753.1997.00094.x","article-title":"Evidence-based medicine, practice variations and clinical freedom","volume":"3","author":"Hampton","year":"1997","journal-title":"J Eval Clin Pract"},{"issue":"7225","key":"10.1016\/S1353-8020(02)00039-1_BIB2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/bmj.319.7225.1618","article-title":"Seven alternatives to evidence based medicine","volume":"319","author":"Isaacs","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB3","first-page":"837","article-title":"Evidence-based medicine: a commentary on common criticisms","volume":"163","author":"Straus","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(01)05548-9","article-title":"The art and science of clinical knowledge: evidence beyond measures and numbers","volume":"358","author":"Malterud","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/S1353-8020(02)00039-1_BIB5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.71.5.569","article-title":"Evidence based medicine: concerns of a clinical neurologist","volume":"71","author":"Caplan","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB6","series-title":"Evidence-based medicine: how to practice and teach EBM","author":"Sackett","year":"2000"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB7","series-title":"Personal knowledge: towards a post-critical philosophy","author":"Polanyi","year":"1958"},{"issue":"25","key":"10.1016\/S1353-8020(02)00039-1_BIB8","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomised, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/S1353-8020(02)00039-1_BIB9","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomised, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.317.7167.1185","article-title":"The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials","volume":"317","author":"Kunz","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/bmj.319.7205.312","article-title":"Methods in health services research: interpreting the evidence: choosing between randomised and non-randomised studies","volume":"319","author":"McKee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB12","unstructured":"CPMP\/2457\/98 (http:\/\/www.emea.eu.int\/pdfs\/human\/press\/pr\/245798en.pdf) Recommendation for the Suspension of the Market Authorisation for TASMAR (Tolcapone)."},{"key":"10.1016\/S1353-8020(02)00039-1_BIB13","unstructured":"CPMP\/2986\/01 (http:\/\/www.emea.eu.int\/pdfs\/human\/press\/pus\/298601en.pdf) Recommendation for the Renewal of the Suspension of the Market Authorisation for TASMAR (Tolcapone)."},{"key":"10.1016\/S1353-8020(02)00039-1_BIB14","series-title":"Clinical evidence issue 6","author":"Sampaio","year":"2001"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB15","series-title":"Clinical evidence issue 6","author":"Moore","year":"2001"},{"issue":"4","key":"10.1016\/S1353-8020(02)00039-1_BIB16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mds.870120402","article-title":"Movement disorders cochrane collaborative review group","volume":"12","author":"Clarke","year":"1997","journal-title":"Mov Disorder"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB17","article-title":"Management of Parkinson's disease: an evidenced-based review","author":"Goetz","year":"2002","journal-title":"Mov Disorder"},{"issue":"7","key":"10.1016\/S1353-8020(02)00039-1_BIB18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jama.274.7.570","article-title":"How to use a clinical practice guideline, A: are the recommendations valid?","volume":"274","author":"Hayward","year":"1995","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/S1353-8020(02)00039-1_BIB19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.1995.03530070068032","article-title":"How to use a clinical practice guideline, B: what are the recommendations and will they help you in caring for your patients?","volume":"274","author":"Hayward","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1212\/WNL.58.1.11","article-title":"Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"58","author":"Miyasaki","year":"2002","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/S1353-8020(02)00039-1_BIB21","first-page":"281","article-title":"Recommendations of the jury on diagnosis and treatment of Parkinson disease. Long text","volume":"156","year":"2000","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB22","first-page":"11","article-title":"Gu\u0131\u0301as de Pr\u00e1ctica Cl\u0131\u0301nica en Enfermedad de Parkinson","author":"Kulisevsky","year":"1999","journal-title":"Neurologia"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB23","unstructured":"Macedo A, Nunes S, Ferreira JJ, Castro-Caldas A, Dur\u00e3o V, Sampaio C. In: Korczyn A, editor. A Survey of the Evidence on the Treatment of Parkinson's 4th Congress of the European Society of Clinical Neuropharmacology. Monduzzi Editore, 1997, p. 85\u201391."},{"issue":"9191","key":"10.1016\/S1353-8020(02)00039-1_BIB24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(99)03556-4","article-title":"Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial","volume":"354","author":"de Bie","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/S1353-8020(02)00039-1_BIB25","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/00006123-199912000-00024","article-title":"Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study","volume":"45","author":"Burchiel","year":"1999","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/S1353-8020(02)00039-1_BIB26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jnnp.70.4.464","article-title":"Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus","volume":"70","author":"Krause","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/S1353-8020(02)00039-1_BIB27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/S1353-8020(02)00039-1_BIB28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/S1353-8020(02)00039-1_BIB29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199855001-00004","article-title":"Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial","volume":"55","author":"Rinne","year":"1998","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/S1353-8020(02)00039-1_BIB30","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial","volume":"284","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/S1353-8020(02)00039-1_BIB31","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.57.9.1687","article-title":"Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial","volume":"57","author":"Lees","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S1353-8020(02)00039-1_BIB32","unstructured":"Sampaio C. International Congress of Movement Disorders. Barcelona, June 2000 (personal communication)."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802002000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802002000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:58:55Z","timestamp":1554839935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802002000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S1353802002000391"],"URL":"https:\/\/doi.org\/10.1016\/s1353-8020(02)00039-1","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}